Mirati Therapeutics reported $53.95M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 31.51M 13K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amgen AMGN:US $ 1.23B 197M
Astellas Pharma 4503:JP 142.42B 6.51B
AstraZeneca AZN:LN 3.06B 1.03B
Bayer BAYN:GR 3.94B 346M
Biocryst Pharmaceuticals BCRX:US $ 34.28M 1.1M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Eisai 4523:JP 110.49B 9.03B
Eli Lilly And LLY:US $ 1.56B 34.1M
Exelixis EXEL:US $ 102.86M 3.55M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
IONIS PHARMACEUT IONS:US $ 34.13M 3.47M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Merk MRK:US $ 2.3B 518M
Moderna Inc MRNA:US 268M 67M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Novartis NOVN:VX 3.5B 486M
Puma Biotechnology PBYI:US $ 20.4M 2.06M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Spectrum Pharmaceuticals SPPI:US $ 9.87M 9.02M
Takeda 4502:JP 223.43B 7.65B
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
YTE INCY:US $ 209.58M 16.62M